Mahmoud Abdelaal, PMP, CISM, CSM

At Neosoma, we stand at the crossroads where cutting-edge science meets compassionate care. Our mission is to design and deploy clinician-centric, A.I. powered neurodiagnostic solutions. Our advanced tools cater to neuroradiologists, radiation oncologists, neurologists, neurosurgeons, and neuroscience researchers. Our prime objective is to enhance the research, diagnosis, treatment, and clinical trials pertaining to brain cancers. Our patented, FDA-approved technology offerings bridge the gap between raw data and actionable insights. They ensure the right, precise information is at the physicians fingertips exactly when its needed. Moreover, our solutions integrate smoothly within existing workflows and facilitate seamless collaboration amongst all the professionals engaged in the care of brain cancer patients. At Neosoma, we draw our strength from the seasoned practicing physicians and software industry veterans who form our leadership. This unique blend enables us to develop world-class software that prioritizes the needs of both patients and physicians. We firmly believe this patient-centric, physician-first approach will trigger the most substantial positive impact on our patients health outcomes and resonate profoundly within our community. Our collaborations extend to some of the most progressive and innovative health systems across the US. We invite you to explore how our FDA-approved technologies can catalyze the growth and effectiveness of your NeurOnc. Practice. Please get in touch to learn more about the difference Neosoma can make!

At Neosoma, we stand at the crossroads where cutting-edge science meets compassionate care. Our mission is to design and deploy clinician-centric, A.I. powered neurodiagnostic solutions. Our advanced tools cater to neuroradiologists, radiation oncologists, neurologists, neurosurgeons, and neuroscience researchers. Our prime objective is to enhance the research, diagnosis, treatment, and clinical trials pertaining to brain cancers. Our patented, FDA-approved technology offerings bridge the gap between raw data and actionable insights. They ensure the right, precise information is at the physicians fingertips exactly when its needed. Moreover, our solutions integrate smoothly within existing workflows and facilitate seamless collaboration amongst all the professionals engaged in the care of brain cancer patients. At Neosoma, we draw our strength from the seasoned practicing physicians and software industry veterans who form our leadership. This unique blend enables us to develop world-class software that prioritizes the needs of both patients and physicians. We firmly believe this patient-centric, physician-first approach will trigger the most substantial positive impact on our patients health outcomes and resonate profoundly within our community. Our collaborations extend to some of the most progressive and innovative health systems across the US. We invite you to explore how our FDA-approved technologies can catalyze the growth and effectiveness of your NeurOnc. Practice. Please get in touch to learn more about the difference Neosoma can make!

Our technology is intelligent, secure, and built for you. So, you can focus on what matters most.

From on-premises to cloud to hybrid, RSA provides identity-first solutions for security-first organizations to thrive in a digital world with modern authentication, lifecycle management, and identity governance.